October 12, 2020 ArticlesCompliance Issues with Cannabis Company InvestmentsNSCP CurrentsBy Joshua Horn and Ellis W. Martin
June 26, 2019 ArticlesFDA Hearing on Cannabis Products—CBD Takes Center StageThe Legal IntelligencerBy Joshua Horn and Ellis Martin